Monday, November 9, 2026

USD/EUR Went Down By Over 3% In The Last 21 Sessions

ViaNews Editorial Team

November 30, 2023

USD/EUR Went Down By Over 3% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 3.24% for the last 21 sessions. At 17:06 EST on Thursday, 30 November, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 3.135% up from its 52-week low and 4.887% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.26%, a negative 0.20%, and a positive 0.32%, respectively.

USD/EUR's highest amplitude of average volatility was 0.26% (last week), 0.37% (last month), and 0.32% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 28 November, "A return to 0.9713 (200-DMA) still appears ambitious with a push in EUR/USD above 1.10."
  • Eur/usd cracks 1.1000 as US dollar recedes across the board. According to FXStreet on Tuesday, 28 November, "The Euro's rally fueled by Greenback-selling across the broader FX marketspace sees the EUR/USD clipping into the 1.1000 handle, climbing four-tenths of a percent with further gains on the cards if market sentiment continues to climb.", "The EUR/USD has ticked into a fresh 15-week high above the 1.1000 major handle on Tuesday, fueled by a broad-market US Dollar (USD) selloff that is sending the Euro (EUR) higher as investor risk appetite climbs heading into the mid-week."
  • Eur/usd refreshes multi-month peak as fed rate cut bets continue to undermine the USD. According to FXStreet on Tuesday, 28 November, "This will be followed by the flash Eurozone CPI report on Thursday and the US Core PCE Price Index - the Fed's preferred inflation gauge - on Thursday, which, in turn, will drive the EUR/USD pair in the near term.", "This, in turn, validates the positive outlook for the EUR/USD pair and supports prospects for a further appreciating move."
  • Eur/usd price analysis: the key contention level is seen at the 1.0890–1.0900 zone. According to FXStreet on Tuesday, 28 November, "The EUR/USD pair snaps the three-day winning streak during the early European session on Tuesday. ", " Technically, the EUR/USD pair maintains a bullish outlook as the major pair holds above the 50- and 100-hour Exponential Moving Averages (EMA) on the four-hour chart. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com